← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Texas Tech University Health Sciences Center
$11,610,284
Total funding
18
Grants
Funding over time
peak $1.9M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$10,502,723 · 16
USDA$1,107,561 · 2
By mechanism
—$11,610,284 · 18
Investigators at Texas Tech University Health Sciences Center
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
ROLE OF TBX2 IN THE ESTABLISHMENT OF THE PROSTATE CANCER PREMETASTATIC NICHE (PMN) IN THE BONE$1,854,473
· FY2025 · Defense Health Agency
PREVENTION OF BREAST CANCER BY HAPLOINSUFFICIENCY OF RALBP1$1,147,500
· FY2018 · Department of the Army
THERAPEUTIC EVALUATION OF MESENCHYMAL STEM CELLS IN CHRONIC GUT INFLAMMATION$1,011,295
· FY2011 · Department of Defense
RECIPROCAL CROSS TALK BETWEEN NOTCH SIGNALING AND HIPPO PATHWAY IN THE TUMOR MICROENVIRONMENT MEDIATES CASTRATE RESISTANT PROSTATE CANCER$901,999
· FY2017 · Department of the Army
STIMULTANEOUS VASCULAR TARGETING AND TUMOR TARGETING OF CEREBRAL BREAST CANCER$724,610
· FY2012 · Department of Defense
COMPLEMENT INHIBITION IN THE IMMUNOTHERAPY OF BREAST CANCER$698,332
· FY2012 · Department of Defense
IDENTIFYING MECHANISMS INITIATING LAM AND ANGIOMYOLIPOMA IN TUBEROUS SCLEROSIS COMPLEX$641,746
· FY2015 · Department of Defense
** AWARDS ISSUED PRIOR TO JANUARY 20, 2025, WERE FUNDED UNDER PREVIOUS ADMINISTRATIONS AND MAY NOT REFLECT THE PRIORITIES AND POLICIES OF THE CURRENT ADMINISTRATION.** NEUROPATHIC PAIN AFFECTS THE QUALITY OF LIFE OF MANY AMERICANS. NON-PHARMACOLOGICAL STRATEGIES SUCH AS BIOACTIVE COMPOUNDS IN FOODS ARE BEING EXPLORED AS THERAPEUTICS BUT CAN ALSO SERVE AS TOOLS TO BETTER UNDERSTAND PAIN MECHANISMS. WE PREVIOUSLY REPORTED GINGER REDUCED NEUROPATHIC PAIN AND FAVORED GUT MICROBIOME IN ANIMALS. THIS STUDY IS TO TEST HOW 2 MONTHS OF GINGER SUPPLEMENTATION WOULD AFFECT INDIVIDUALS WITH SCIATICA. WE PLAN TO RECRUIT DIRECT PERSON-TO-PERSON SONICATION IN CLINICS, HEALTH FAIRS, COMMUNITY EVENTS, FLYERS, NON-SOLICITED EMAIL SYSTEM, CAMPUS ANNOUNCEMENTS, CLINICAL RESEARCH INSTITUTE WEBSITE, LOCAL RADIO, NEWSPAPERS, SENIOR NEWSLETTERS, AND TV SCRIPTS. WE PLAN TO ENROLL APPROXIMATELY 200-250 PATIENTS TO OBTAIN 80-100 QUALIFIED SUBJECTS AT THE START OF THE STUDY. AFTER SCREENING, QUALIFIED PARTICIPANTS WILL BE RANDOMLY ASSIGNED TO A NO-GINGER GROUP OR GINGER GROUP. THIS STUDY WILL FOCUSE ON GUT FUNCATION (GUT MICROBIOTA COMPOSITION, FECAL METABOLITES, AND PLASMA MARKERS FOR LEAKY GUT) (PRIMAYR OUTCOME), BLOOD METABOLIES, AND BRAIN ACTIVITY (SECONDARY OUTCOME). IN ADDITION, THIS STUDY WILL MONITOR SAFETY AS WELL AS THE CHANGES IN DIETARY INTAKE, PHYSICAL ACTIVITY, AND OTC.ALL OUTCOMES WILL BE ASSESSED AT BASELINE AND AFTER 2 MONTHS OF INTERVENTION. DATA WILL BE ANALYZED STATISTICALLY.$607,561
· FY2024 · National Institute of Food and Agriculture
CHARACTERIZING TUMOR EVOLUTION AND THERAPY RESISTANCE IN HIGH-RISK NEUROBLASTOMA$581,096
· FY2020 · Defense Health Agency
HOMOCYSTEINE IS AN ONCOMETABOLITE IN BREAST CANCER, WHICH PROMOTES TUMOR PROGRESSION AND METASTASIS$562,500
· FY2013 · Department of Defense
IMMUNOTHERAPEUTIC TARGETING OF COLON CANCER VASCULARIZATION TO ACHIEVE LONG-TERM IMMUNITY AGAINST PRIMARY AND METASTATIC DISEASE$530,975
· FY2018 · Defense Health Agency
TPD52: A NOVEL VACINE TARGET FOR PROSTATE CANCER$511,235
· FY2008 · Department of Defense
PAIN IS A MAJOR HEALTH CARE PROBLEM AND THE NUMBER ONE REASON FOR PATIENTS TO SEEK MEDICAL HELP. PAIN SERVES A USEFUL WARNING FUNCTION, BUT FOR REASONS NOT WELL UNDERSTOOD, PAIN CAN PERSIST AND DEVELOP INTO A COMPLEX SYNDROME. PERSISTENT OR CHRONIC PAIN IS ASSOCIATED WITH NEGATIVE EMOTIONAL STATES SUCH AS ANXIETY AND DEPRESSION AND WITH COGNITIVE DEFICITS. PAIN AS A COMPLEX DISORDER IS STILL DIFFICULT TO TREAT BECAUSE UNDERLYING MECHANISMS ARE NOT WELL UNDERSTOOD.GINGER IS A WELL-KNOWN SPICE PLANT. GINGER CAN HAVE ANALGESIC AND ANTI-INFLAMMATORY EFFECTS. IT HAS BEEN USED FOR A VARIETY OF PAIN-ASSOCIATED AILMENTS SUCH AS OSTEOARTHRITIS AND OPIATE WITHDRAWAL-INDUCED DISORDERS. HOWEVER, THE EFFECT OF GINGER IN NEUROPATHIC PAIN IS UNCLEAR. IN THIS STUDY, WE WOULD LIKE TO TEST THE EFFECTS OF GINGER ROOT EXTRACT SUPPLEMENTED INTO THE DIET ON PAIN BEHAVIORS OF RATS IN A NEUROPATHIC PAIN MODEL. TWO WEEKS AFTER INDUCTION OF THE PAIN MODEL, THE ANIMALS WILL BE ASSIGNED TO ONE OF FOUR GROUPS. THEY WILL RECEIVE NO OR 3 DIFFERENT DOSES OF GINGER ROOT EXTRACT FOR 5 WEEKS. ALL ANIMALS WILL BE TESTED IN BEHAVIORAL ASSAYS FOR DIFFERENT ASPECTS OF NEUROPATHIC PAIN. AT THE END OF THE EXPERIMENT, WE WILL COLLECT FECES FOR GUT MICROBIOME AND METABOLITES MARKERS AS WELL AS THE TISSUES FOR THE ANALYSIS OF NEURO-INFLAMMATORY MARKERS.$500,000
· FY2021 · National Institute of Food and Agriculture
PHYSIOLOGIC RESPONSE TO PROLONGED RESUSCITATIVE ENDOVASCULAR BALLOON OCCLUSION OF THE THORACIC AORTA IN SWINE$437,500
· FY2016 · Department of the Army
NOVEL PLATINUM/TAXANE-BASED DRUG COMBINATIONS (PRECLINICAL) FOR OVARIAN CANCER$360,142
· FY2016 · Department of the Army
MICROBIOLOGY ENDOCRINOLOGY AS A MECHANISM GOVERNING STRESS-INDUCED MICROBIOME-GUT-BRAIN COMMUNICATION$329,461
· FY2014 · Department of Defense
A CELL SELECTIVE SELENO-CONJUGATE COMPOUND FOR TREATMENT OF HUMAN PROSTATE CANCER$109,774
· FY2011 · Department of Defense
CATIONIC CHEMOTHERAPEUTICS TO PENETRATE BOTH THE BLOOD-BRAIN BARRIER AND BRAIN METASTASIS OF BREAST CANCER CELLS VIA THE CHOLINE TRANSPORTER$100,085
· FY2010 · Department of Defense